REDEMPLO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
84141-025 -
Package NDC
84141-025-01 -
Application number
NDA219947 -
SPL ID
4b987e0d-345d-4ba3-b5d6-d70c1bfe0fd7 -
SPL set ID
7fd37993-f85a-4af1-8bbe-133299f226ed -
UNII
XG9ARL6P25 -
RxCUI
2728183 -
RxCUI
2728184
What the source publishes
- Labeler
- Arrowhead Pharmaceuticals, Inc.
- Active ingredients
- plozasiran
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "REDEMPLO",
"splId": "4b987e0d-345d-4ba3-b5d6-d70c1bfe0fd7",
"labels": [
{
"setId": "7fd37993-f85a-4af1-8bbe-133299f226ed",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fd37993-f85a-4af1-8bbe-133299f226ed",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7fd37993-f85a-4af1-8bbe-133299f226ed"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Arrowhead Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (84141-025-01) / 1 mL in 1 SYRINGE, GLASS",
"package_ndc": "84141-025-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20251119"
}
],
"productId": "84141-025_4b987e0d-345d-4ba3-b5d6-d70c1bfe0fd7",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "84141-025",
"deaSchedule": null,
"genericName": "plozasiran",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PLOZASIRAN",
"strength": "25 mg/.5mL"
}
],
"applicationNumber": "NDA219947",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20251119",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194144",
"N0000193848",
"M0406100",
"N0000194154"
],
"unii": [
"XG9ARL6P25"
],
"rxcui": [
"2728183",
"2728184"
],
"spl_set_id": [
"7fd37993-f85a-4af1-8bbe-133299f226ed"
],
"pharm_class_cs": [
"RNA, Small Interfering [CS]"
],
"pharm_class_pe": [
"Increased RNA Degradation [PE]"
],
"pharm_class_epc": [
"APOC-III-directed RNA Interaction [EPC]",
"Small Interfering RNA [EPC]"
],
"manufacturer_name": [
"Arrowhead Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:84141-025_4b987e0d-345d-4ba3-b5d6-d70c1bfe0fd7"